Derivation of Mesenchymal Stem Cells from Human Embryonic Stem Cells

Methods in Molecular Biology

Volumn 690, Issue , 2011, Pages 175-182

  Choo, Andre ^a   Lim, Sai Kiang ^b,c  

^a AGENCY FOR SCIENCE   (Singapore)

^b INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

CD105; CD24; CD73; Flow cytometry; Human embryonic stem cells; Mesenchymal stem cells

Indexed keywords

CD24 ANTIGEN; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ARTICLE; CELL LINE; CELL SHAPE; CULTURE TECHNIQUE; CYTOLOGY; EMBRYONIC STEM CELL; FREEZING; HUMAN; MESENCHYMAL STEM CELL; METABOLISM; METHODOLOGY;

ANTIGENS, CD; ANTIGENS, CD24; CELL CULTURE TECHNIQUES; CELL LINE; CELL SHAPE; EMBRYONIC STEM CELLS; FREEZING; HUMANS; MESENCHYMAL STEM CELLS; RECEPTORS, CELL SURFACE;

EID: 79952200535     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-962-8_12     Document Type: Chapter

References (12)

1. Wagner, W., and Ho, A.D. (2007) Mesenchymal stem cell preparations-comparing apples and oranges. Stem Cell Rev. 3, 239–248.
2. Brooke, G., Cook, M., Blair, C., Han, R., Heazlewood, C., Jones, B., et al. (2007) Therapeutic applications of mesenchymal stromal cells. Semin. Cell. Dev. Biol. 18, 846–858.
3. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315–317.
4. Barberi, T., Willis, L.M., Socci, N.D., and Studer, L. (2005) Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med. 2, e161.
5. Lian, Q., Lye, E., Suan Yeo, K., Khia Way Tan, E., Salto-Tellez, M., Liu, T.M., et al. (2007) Derivation of clinically compliant MSCs from CD105+, CD24− differentiated human ESCs. Stem Cells 25, 425–436.
6. Olivier, E.N., Rybicki, A.C., and Bouhassira, E.E. (2006) Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells 24, 1914–1922.
7. Caplan, A.I., and Dennis, J.E. (2006) Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. 98, 1076–1084.
8. Sze, S.K., de Kleijn, D.P., Lai, R.C., Khia Way Tan, E., Zhao, H., Yeo, K.S., et al. (2007) Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. Mol. Cell. Proteomics 6, 1680–1689.
9. Timmers, L., Lim, S.K., Arslan, F., Armstrong, J.S., Hoefer, I.E., Doevendans, P.A., et al. (2007) Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res. 1, 129–137.
10. Choo, A., Ngo, A.S., Ding, V., Oh, S., and Kiang, L.S. (2008) Autogeneic feeders for the culture of undifferentiated human embryonic stem cells in feeder and feeder-free conditions. Methods Cell Biol. 86, 15–28.
11. Cowan, C.A., Klimanskaya, I., McMahon, J., Atienza, J., Witmyer, J., Zucker, J.P., et al. (2004) Derivation of embryonic stem-cell lines from human blastocysts. N. Engl. J. Med. 350, 1353–1356.
12. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–1147.